Please login to the form below

Precision medicine from concept to clinic

In our latest edition of ‘Perspective’ magazine, we examine the challenges and opportunities for several stakeholders impacted by the dawn of precision medicine

In this edition of ‘Perspective ’, the magazine of Blue Latitude Health, we examine the challenges and opportunities that have risen with the dawn of precision medicine.

The emergence of new targeted therapies and diagnostic tests have led to a more complex network of stakeholders than ever before. Now, industry is working with new players who each have a variety of needs, challenges and pain points.

We have spoken to these stakeholders to chart their journeys and the role they play in ensuring patients can access precision medicines. Read on to hear from patients, healthcare professionals, scientists, those transforming healthcare systems, diagnostic experts, and executives at innovative pharmaceutical companies.

Find out their personal stories and gain a behind-the-scenes look at the role they play in driving novel healthcare innovations. Once you have learned from these first-hand accounts, turn to our precision medicine ecosystem, which begins on p.50 . Here, we reveal key insights to help you meet the needs of seven core stakeholders involved in launching and delivering precision medicines.

Blue Latitude Health works with commercial and medical teams in top pharmaceutical companies and innovative biotechs. Our capabilities, from insight and strategy to creative execution, ensure we can solve our clients’ end-to-end commercial challenges. Our early stage service is specifically designed to help launch cutting-edge products, ensuring our clients make a real difference in patients’ lives.

Download the publication to learn:

* An overview of how precision medicine is impacting stakeholders across the precision medicine ecosystem

* Breast cancer patient Laura Holmes Haddad’s story of taking part in a novel PARP inhibitor clinical trial

* Laura oncologist gives his perspective of the PARP inhibitor clinical trial along with his advice for industry

* What it’s like to treating paediatric patients with CAR-T at Great Ormond Street Children’s hospital

* How Genomics England is rolling out precision medicine across the nation

* Nancy Brandt explains how a top biopharma company is transforming internally to ensure it sits at the forefront of innovation

* Insights from seven key stakeholders, from payers and regulators, to healthcare technology, diagnostic companies, pharmaceuticals, healthcare professionals and patients.

Download the full publication here

31st May 2019

Share

Tags

Company Details

Blue Latitude Health

+44 203 328 1840

Contact Website

Address:
Blue Latitude Health (UK)
140 Aldersgate Street
London
EC1A 4HY
United Kingdom

Latest content on this profile

Precision medicine at Blue Latitude Health
At Blue Latitude Health we have identified 90+ insights about commercialising precision medicines. Check out our video to get a run down on three core components of the commercialisation and launch of precision medicines.
Blue Latitude Health
Understanding the evolving CAR-T market
In 2017 the approval of the first CAR-T treatment took the world by storm, transforming the way cancer is treated, but two years later more than 500 CAR-Ts are in development. So how can pharma ensure its product stands out from the crowd?
Blue Latitude Health
How ready are you for launch?
Pharmaceutical launches are becoming more complex and competitive. Our launch excellence diagnostic tool helps you to map how ready you are for launch, while facilitating success in this challenging environment.
Blue Latitude Health
Does your pre-launch strategy really drive behaviour change?
One of the most interesting parts of a pharmaceutical launch is delving into the minds of stakeholders to understand why they behave in the way that they do. Blue Latitude Health Insight Consultant, Dorrotya Okros, examines how we use these insights to understand customers decision making behaviour, in order to make smarter business decisions.
Blue Latitude Health
Digitalising healthcare: what can the NHS learn from other industries?
Expensive digital solutions are often disregarded because they do not work well for the end user. Account Manager Fiona Grace explores this challenge and reveals the stories of innovation we can all learn from.
Blue Latitude Health
UK vs US: what makes a successful immunisation programme?
Emily Macdonald calls on her experience as a public health nurse specialising in the prevention of infectious disease in both the US and UK, to explore the differences between immunisation programmes in the two countries. She explores the challenges, opportunities for improvement, and asks why vaccination rates are falling.
Blue Latitude Health